Investors

Homology Medicines is focused on advancing our genetic medicines platform as one-time treatments and potential cures for patients with rare diseases

Homology Medicines is focused on advancing our genetic medicines platform as one-time treatments and potential cures for patients with rare diseases

Document Details

Form

Filing Date

Jun 17, 2022

Document Date

Jun 17, 2022

Form Description

Statement of changes in beneficial ownership of securities

Filing Group

3,4,5

Company

Homology Medicines, Inc.

Issuer

Homology Medicines, Inc.

Filer

PARMAR KUSH

Filing Formats

View HTML

MENU